quality and efficiency of clinical trials.
CTTI Project Category: AB Drug Development
Project Status: Current
Advances in clinical trial design over the past decade have offered new and accelerated pathways for drug development in general. Despite this, the development of novel antibacterial therapies is still lagging due to scientific and economic challenges. Meanwhile, resistance to currently available antibiotics is on the rise, and the absence of new antibacterial drugs has become a critical public health need. New, non-traditional approaches are needed to address this unmet need.
Most Visited Pages
CTTI encourages the use of all materials listed on this site in the pursuit of improving the clinical trials enterprise. Our recommendations, tools, meeting summaries, and more are available to the public for free. We do ask that you acknowledge the source whenever using or referencing CTTI materials. Read our Citation Policy here.